Axillofemoral bypass: a critical reappraisal of its role in the management of aortoiliac occlusive disease.
Two hundred twenty-four consecutive patients (361 graft limbs) who underwent bypass grafting with the USCI Sauvage filamentous velour Dacron arterial prosthesis for aortoiliac occlusive disease over the 9 year period 1970 to 1979 are reviewed. Eighty-four axillofemoral (23 percent of patients), 210 aortofemoral (47 percent of patients), and 67 femorofemoral grafts (30 percent of patients) had cumulative patency rates of 72.1, 91.1, and 86.4 percent, respectively. Experimental and clinical factors influencing the patency of axillofemoral  grafts are discussed, and the concept of an improved porous Dacron prosthesis specific for the axillofemoral site is presented.
D000368:Aged; D001011:Aorta / Q000601:surgery; D001018:Aortic Diseases / Q000601:surgery*; D001157:Arterial Occlusive Diseases / Q000601:surgery*; D001366:Axillary Artery / Q000601:surgery*; D001807:Blood Vessel Prosthesis; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D006801:Humans; D007083:Iliac Artery / Q000601:surgery*; D008297:Male; D008722:Methods; D008875:Middle Aged; D011093:Polyethylene Terephthalates; D011183:Postoperative Complications; D012306:Risk
D011093:Polyethylene Terephthalates